Bandingkan Harga & Kinerja Mandala Multifinance Tbk. (MFIN) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Mandala Multifinance Tbk. dan Organon Pharma Indonesia Tbk.: Mandala Multifinance Tbk. diperdagangkan di Rp890 (kapitalisasi pasar 4,45 T), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Mandala Multifinance Tbk. jauh lebih besar — sekitar 42,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MFIN | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 4,45 T | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Mandala Multifinance Tbk.
PT Mandala Multifinance Tbk (the Company) was established under its original name of PT Vidya Cipta Leasing Corporation on Aug 13th, 1983, then changed to PT Lautan Berlian Leasing at 1990. On 1996 company's name changed to PT Gracia Dinamika Mulifinance and in 1997 the name changed to PT Mandala Multifinance.The articles of association has been amended most recently by notarial deed no 34 dated 28 Apr 2005 concerning among others, the change in the company's name and public offering of stock.
Selengkapnya di halaman MFIN →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
